These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9030403

  • 21. Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6-hydroxydopamine and 5,7-dihydroxytryptamine lesions.
    Porceddu ML, Imperato A, Melis MR, Di Chiara G.
    Brain Res; 1983 Mar 07; 262(2):187-200. PubMed ID: 6404501
    [Abstract] [Full Text] [Related]

  • 22. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME, Yuwiler A.
    Psychopharmacology (Berl); 1985 Mar 07; 87(4):484-9. PubMed ID: 3936107
    [Abstract] [Full Text] [Related]

  • 23. Role of dopaminergic system(s) in mediation of the behavioural effects of bombesin.
    Merali Z, Johnston S, Sistek J.
    Pharmacol Biochem Behav; 1985 Aug 07; 23(2):243-8. PubMed ID: 3933020
    [Abstract] [Full Text] [Related]

  • 24. Role of dopaminergic system in core part of nucleus accumbens in hyperlocomotion and rearing induced by MK-801 in rats: a behavioral and in vivo microdialysis study.
    Hatip-Al-khati I, Bölükbasi F, Mishima K, Egashira N, Iwasaki K, Fujiwara M.
    Jpn J Pharmacol; 2001 Dec 07; 87(4):277-87. PubMed ID: 11829147
    [Abstract] [Full Text] [Related]

  • 25. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA.
    J Pharmacol Exp Ther; 1984 Nov 07; 231(2):343-54. PubMed ID: 6149306
    [Abstract] [Full Text] [Related]

  • 26. Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.
    Gong L, Kostrzewa RM, Li C.
    J Neurochem; 1994 Oct 07; 63(4):1282-90. PubMed ID: 7931280
    [Abstract] [Full Text] [Related]

  • 27. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J, Fredriksson A, Lewander T, Jonsson G, Archer T.
    Psychopharmacology (Berl); 1989 Oct 07; 99(4):550-7. PubMed ID: 2594922
    [Abstract] [Full Text] [Related]

  • 28. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E, Zhang K, Tarazi FI, Baldessarini RJ.
    Psychopharmacology (Berl); 2002 Feb 07; 160(1):92-8. PubMed ID: 11862378
    [Abstract] [Full Text] [Related]

  • 29. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.
    Luthman J, Herrera-Marschitz M, Lindqvist E.
    Psychopharmacology (Berl); 1994 Dec 07; 116(4):443-50. PubMed ID: 7701047
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR, Stodgell CJ, Schroeder SR, Tessel RE.
    Brain Res; 1998 Jan 05; 780(1):56-66. PubMed ID: 9473587
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F, Ettenberg A, Koob GF.
    Psychopharmacology (Berl); 1989 Jan 05; 99(3):409-15. PubMed ID: 2574480
    [Abstract] [Full Text] [Related]

  • 38. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze.
    Bubser M, Schmidt WJ.
    Behav Brain Res; 1990 Mar 05; 37(2):157-68. PubMed ID: 2108704
    [Abstract] [Full Text] [Related]

  • 39. Neonatal 6-hydroxydopamine potentiates clonidine's locomotor effects throughout maturation in the rat.
    Smythe JW, Pappas BA.
    Pharmacol Biochem Behav; 1985 Jun 05; 22(6):1075-8. PubMed ID: 3927324
    [Abstract] [Full Text] [Related]

  • 40. Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections.
    Schwarting RK, Bonatz AE, Carey RJ, Huston JP.
    Brain Res; 1991 Jul 19; 554(1-2):46-55. PubMed ID: 1933318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.